Skip to main content

Table 3 Prolactin and total cholesterol levels (mean ± SD) according to treatment group and evaluation moment

From: Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study

Measurement Serum Levels in Treatment Group p-value*
  A (1 g) B (2 g) C (Placebo)  
Prolactin     
   Baseline 7.54 ± 2.1 7.87 ± 2.5 8.24 ± 3.4  
   6 months 7.03 ± 1.7 7.75 ± 2.7 7.58 ± 3.5 0.3282
Total cholesterol     
   Baseline 178.8 ± 13.9 172.6 ± 28.1 180.2 ± 14.1  
   6 months 176.2 ± 14.3 177.1 ± 10.2 179.2 ± 14.8 0.3364
  1. * Comparison of the relative variation (%) between groups (ANOVA).